Medpace Holdings (MEDP) Long-Term Deferred Tax (2015 - 2026)

Medpace Holdings (MEDP) has reported Long-Term Deferred Tax for 12 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax fell 95.09% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2026 stood at $3.2 million (down 95.09% YoY), and the FY2025 full-year result was $19.2 million, down 80.85% from the prior year.
• Long-Term Deferred Tax steadied at $3.2 million in Q2 2026 per MEDP's latest filing, from $3.2 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $100.4 million in Q4 2024 and bottomed at $3.2 million in Q1 2026.
• Historically, Long-Term Deferred Tax has averaged $51.0 million across 5 years, with a median of $50.5 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax soared 4796.48% in 2022, then slumped 96.77% in 2026.
• Over 5 years, Long-Term Deferred Tax stood at $48.1 million in 2022, then soared by 54.81% to $74.4 million in 2023, then jumped by 34.83% to $100.4 million in 2024, then sank by 80.85% to $19.2 million in 2025, then slumped by 83.19% to $3.2 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $3.2 million, $3.2 million, and $19.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.